FORM OF INDEMNIFICATION AGREEMENTIndemnification Agreement • July 11th, 2013 • Onconova Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 11th, 2013 Company Industry JurisdictionThis Indemnification Agreement (the “Agreement”) is made and entered into this [·] day of [·], 2013, by and between Onconova Therapeutics, Inc., a Delaware corporation (the “Company,” which term shall include, where appropriate, any Entity (as hereinafter defined) controlled directly or indirectly by the Company), and [·] (the “Indemnitee”).
EIGHTH AMENDED AND RESTATED STOCKHOLDERS’ AGREEMENTStockholders Agreement • July 11th, 2013 • Onconova Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 11th, 2013 Company Industry JurisdictionTHIS EIGHTH AMENDED AND RESTATED STOCKHOLDERS’ AGREEMENT (this “Agreement”) made as of July 27, 2012, by and among Onconova Therapeutics, Inc., a Delaware corporation (the “Corporation”), the persons listed as owners of Series A Preferred Stock on Schedule I hereto (the “Series A Investors”), the persons listed as owners of Series B Preferred Stock on Schedule I hereto (the “Series B Investors”), the persons listed as owners of Series C Preferred Stock on Schedule I hereto (the “Series C Investors”), the persons listed as owners of Series D Preferred Stock on Schedule I hereto (the “Series D Investors”), the persons listed as owners of Series E Preferred Stock on Schedule I hereto (the “Series E Investors”), the persons listed as owners of Series F Preferred Stock on Schedule I hereto (the “Series F Investors”), the persons listed as owners of Series G Preferred Stock and/or Warrants to purchase Series G Preferred Stock (the “Series G Warrants”) on Schedule I hereto (the “Series G Inve
AMENDMENT NO. 1 TO EIGHTH AMENDED AND RESTATED STOCKHOLDERS’ AGREEMENT Dated as of July 9, 2013Stockholders’ Agreement • July 11th, 2013 • Onconova Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 11th, 2013 Company Industry JurisdictionReference is made to that certain Eighth Amended and Restated Stockholders’ Agreement, dated July 27, 2012 (the “Stockholders’ Agreement”), by and among Onconova Therapeutics, Inc., a Delaware corporation (the “Corporation”) and the Stockholders (as that term is defined in the Stockholders’ Agreement). All capitalized terms used and not otherwise defined herein have the respective meanings given to them in the Stockholders’ Agreement.